Lifecore Biomedical, Inc. (LFCR) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Lifecore Biomedical, Inc. (LFCR) closed at USD 6.42 on 2026-10-14, a change of -7 % over the past year, with a market capitalization of USD 244.11M.

Lifecore Biomedical, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Lifecore Biomedical, Inc. key figures

Previous close

USD 6.42 (2026-10-14)

1-year change

-7 %

Market cap

USD 244.11M

Enterprise value

USD 433.09M

P/E ratio (trailing)

-5.07

P/E ratio (forward)

-8.26

EPS (trailing)

-1.27

EPS (forward)

-0.78

PEG ratio

2.66

Price to book

-7.12

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.32

Employees

382

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Lifecore Biomedical, Inc. and compare it with other stocks.